CCi — Header
CCi — Insights
Insights

Weekly perspective on the
Italian MedTech market.

Not news aggregation. Not press releases. Clodio's direct point of view on what's changing in Italian healthcare, what's failing and what actually works — drawn from 20+ years in the field.

All Market Entry Regulation Sales Strategy KOL & Procurement Distribution
Published on LinkedIn

Insights are published weekly on Clodio's LinkedIn profile — and collected here.

Follow the profile to receive each post directly in your feed. No email list, no subscription required. Just direct access to a practitioner's perspective on the Italian MedTech market.

Follow Clodio on LinkedIn
Sales Strategy 02

Sales networks in MedTech: why structure matters more than numbers

Adding more reps doesn't fix a structural problem. The five questions to ask before you hire your next Italian sales rep.

Read on LinkedIn
Procurement 03

Market entry in healthcare: when speed becomes the biggest risk

Moving fast into Italy without preparation costs more than moving slow with the right guide. The mistakes I see repeated every year.

Read on LinkedIn
Regulation 04

Italy MDR 2026: what's changing for international companies entering now

The regulatory landscape has shifted. Here's what international companies entering Italy today need to know before their first SSN tender.

Read on LinkedIn
KOL Strategy 05

When commercial strategy conflicts with clinical excellence

The tension between what KOLs want and what your sales team wants is real — and navigating it is one of the most underestimated skills in Italian MedTech.

Read on LinkedIn
Distribution 06

5 things international MedTech companies get wrong about Italian healthcare

From procurement assumptions to cultural misreadings — the five errors I see from companies of every size, every year, without fail.

Read on LinkedIn
Market Entry 07

The distributor problem: why most companies choose wrong and pay for it

Selecting the wrong distributor is the single most common and most expensive mistake international MedTech companies make in Italy. Here's how to get it right.

Read on LinkedIn
Procurement 08

How the Italian SSN actually makes purchase decisions — and what it means for your device

The official procurement process and what actually drives decisions in Italian hospitals are two different things. Understanding both is the only way to navigate them.

Read on LinkedIn
Sales Strategy 09

Temporary management vs. full-time hire: the honest comparison no one makes

When does it make sense to hire a Country Manager, and when is temporary management the better option? The answer depends on your market stage — and most companies get it wrong.

Read on LinkedIn
KOL Strategy 10

Building KOL relationships in Italy: the three mistakes that kill them before they start

Most KOL engagement programmes fail not because of the product but because of the approach. The three errors I see most often — and how to avoid them.

Read on LinkedIn
All insights on LinkedIn

New posts every week. Follow to receive them directly.

The full archive of insights is on Clodio's LinkedIn profile. Follow the page to receive each new post in your feed — no subscription, no email list, no noise.

Follow Clodio on LinkedIn
Ready to go beyond reading?

If any of this resonates with your situation in Italy, let's talk.

A 30-minute call is enough to move from insight to a concrete plan for your device and your market stage.

Schedule a free 30-min call
CCi — Footer